SEC Form 4 · accession 0001302605-26-000002
Aurinia Pharmaceuticals Inc. · AUPH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Tina Susan Nova
Director
Period of report
Jun 4, 2026
Accepted (ET)
Jun 8, 2026 · 4:10 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001600620
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Director Stock Option (right to buy)F1 | $15.67 | Jun 4, 2026 | A | 23,931 | A | — | Jun 4, 2036 | Common Shares | 23,931 | 23,931 | D |
Explanation of responses
- F1The options shall vest one year from date of grant.